Mauro Maccarrone, Massimo Taccone-Gallucci, Alessandro Finazzi-Agrò

Slides:



Advertisements
Similar presentations
Plasma sodium and hypertension
Advertisements

Atsushi Tanaka, Richard J. Youle  Molecular Cell 
Study may improve survival of transplanted livers
Anemia management in chronic kidney disease
Mitchell H. Rosner, W. Kline Bolton  Kidney International 
Dylan Burger, Adeera Levin  Kidney International 
Surviving the Cytochrome Seas
Macrophage heterogeneity, phenotypes, and roles in renal fibrosis
Volume 69, Issue 8, Pages (April 2006)
Progression of renal failure and hypertensive nephrosclerosis
Gene electrotransfer: Potential for gene therapy of renal diseases
M. Fukagawa, S. Nakanishi, J.J. Kazama  Kidney International 
The impact of cold ischemia time on renal transplant outcome
Volume 85, Issue 3, Pages (March 2014)
Volume 70, Pages S21-S25 (December 2006)
George A. Kaysen, Burl R. Don
Cell apoptosis and hemodialysis-induced inflammation
Lucifer's Labyrinth—Ten Years of Path Finding in Cell Death
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Oxidative stress and mitochondrial dysfunction in sepsis
Anemia management and chronic renal failure progression
Cees G.M. Kallenberg, Peter Heeringa  Kidney International 
Edmund G. Lowrie  Kidney International 
Study of Heart and Renal Protection (SHARP)
Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes  Choong H. Kim, Nosratola D. Vaziri  Kidney.
Volume 73, Pages S5-S17 (April 2008)
Ming Zhan, Craig Brooks, Fuyou Liu, Lin Sun, Zheng Dong 
Volume 70, Issue 10, Pages (November 2006)
Volume 70, Issue 12, Pages (December 2006)
Frank Eitner, Jürgen Floege  Kidney International 
Volume 72, Issue 8, Pages (October 2007)
New insights in uremic toxins
Clifford J. Holmes, Dirk Faict  Kidney International 
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Tilman B. Drüeke, Ziad A. Massy  Kidney International 
Volume 85, Issue 5, Pages (May 2014)
AGEs in foods: Do they play a role in uremia?
Wayel Jassem, Nigel D. Heaton  Kidney International 
Nitric oxide, oxidative stress, and apoptosis
Counteracting progression of renal disease: A look into the future
Rajnish Mehrotra, Joel D. Kopple, Marsha Wolfson  Kidney International 
Oxidative stress and apoptosis
Volume 75, Issue 9, Pages (May 2009)
Hydrogen: another gas with therapeutic potential
Apoptosis in ischemic renal injury: Roles of GTP depletion and p53
Oxidant stress in hemodialysis: Prevention and treatment strategies
Peritoneal dialysis in Mexico
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Current status of maintenance hemodialysis in Beijing, China
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Phosphate binders on iron basis: A new perspective?
Clinical benefits of slowing the progression of renal failure
Atherosclerotic nephropathy
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
740. Prevention of Radiation-Induced Lung Injury by Administration of Gene-Modified Mesenchymal Stem Cells    Molecular Therapy  Volume 20, Pages S285-S286.
Volume 77, Issue 10, Pages (May 2010)
Elevated plasma F2-isoprostanes in patients on long-term hemodialysis
Volume 80, Issue 10, Pages (November 2011)
Effect of lipid-lowering strategies on tubular cell biology
Is it the low-protein diet or simply the salt restriction?
Charles A. Herzog  Kidney International 
Volume 70, Issue 3, Pages (August 2006)
Volume 75, Issue 7, Pages (April 2009)
Study may improve survival of transplanted livers
Volume 84, Issue 6, Pages (December 2013)
Swollen Nuclei Signal from the Grave
The End and After: How Dying Cells Impact the Living Organism
Prevention of vascular calcification with bisphosphonates without affecting bone mineralization: a new challenge?  Ellen G. Neven, Marc E. De Broe, Patrick.
Oxidative stress in hemodialysis patients: Is NADPH oxidase complex the culprit?  Marion Morena, Jean-Paul Cristol, Lynne Senécal, Helene Leray-Moragues,
Presentation transcript:

Mauro Maccarrone, Massimo Taccone-Gallucci, Alessandro Finazzi-Agrò 5-Lipoxygenase-mediated mitochondrial damage and apoptosis of mononuclear cells in ESRD patients  Mauro Maccarrone, Massimo Taccone-Gallucci, Alessandro Finazzi-Agrò  Kidney International  Volume 63, Pages S33-S36 (May 2003) DOI: 10.1046/j.1523-1755.63.s84.26.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Interplay between vitamin E, 5-lipoxygenase, mitochondrial damage, and apoptosis of mononuclear cells. ESRD patients on maintenance HD show enhanced 5-lipoxygenase (5-LOX) activity in peripheral blood mononuclear cells, which leads to increased membrane lipoperoxides and cytosolic reactive oxygen species (ROS), and to reduced mitochondrial membrane potential (ΔΨ). The increased cytochrome c (cyt c) release from mitochondria activates the caspase cascade, which, together with lipoperoxide and ROS formation, triggers nuclear alterations and ultimately leads to apoptosis. Oral or intramuscular (IM) administration of vitamin E, as well as the filter-bound form, increases the plasma level of vitamin E, which prevents ESRD/HD-induced apoptosis by directly inhibiting 5-LOX activity. Kidney International 2003 63, S33-S36DOI: (10.1046/j.1523-1755.63.s84.26.x) Copyright © 2003 International Society of Nephrology Terms and Conditions